Nuwellis, Inc. (NUWE): R&D Expense
$2.71M
Year ended 2025-12-31
$4.16M
Trailing 12 months to 2026-06-30
-14.5%
3-year compound annual growth
-5.9%
5-year compound annual growth
-17.1%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.71M | -15.5% | 2026-03-11, From 2025-01-01 |
| 2024-12-31 | $3.21M | -40.8% | 2026-03-11, From 2024-01-01 |
| 2023-12-31 | $5.42M | +24.9% | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | $4.34M | -12.8% | 2024-03-11, From 2022-01-01 |
| 2021-12-31 | $4.98M | +35.7% | 2023-03-03, From 2021-01-01 |
| 2020-12-31 | $3.67M | -21.5% | 2022-03-03, From 2020-01-01 |
| 2019-12-31 | $4.67M | +53.0% | 2021-03-25, From 2019-01-01 |
| 2018-12-31 | $3.05M | +106.1% | 2020-03-05, From 2018-01-01 |
| 2017-12-31 | $1.48M | -81.7% | 2019-02-21, From 2017-01-01 |
| 2016-12-31 | $8.11M | -54.1% | 2018-03-22, From 2016-01-01 |
| 2015-12-31 | $17.67M | +4.7% | 2017-03-08, From 2015-01-01 |
| 2014-12-31 | $16.87M | +25.0% | 2016-03-15, From 2014-01-01 |
| 2013-12-31 | $13.50M | +68.7% | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | $8.00M | -28.5% | 2014-03-14, From 2012-01-01 |
| 2011-12-31 | $11.20M | n/a | 2013-03-12, From 2011-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $2.71M | -15.5% |
| Escalon Medical Corp (ESMC) | 2025-06-30 | $753.1K | +9.4% |
| CapsoVision, Inc (CV) | 2025-12-31 | $18.31M | +21.1% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $17.45M | -22.4% |
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $3.94M | +20.5% |
| Precision Optics Corporation, Inc. (POCI) | 2025-06-30 | $1.16M | +17.9% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $493.6K | +13.8% |
| ADM Tronics Unlimited, Inc. (ADMT) | 2026-03-31 | $545.0K | +5.4% |
| electroCore, Inc. (ECOR) | 2024-12-31 | $2.36M | -55.6% |
Compare NUWE, ESMC, CV, HYPR side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗